Learn about the new therapy approved by the Food and Drug Administration for Alzheimer’s disease. Dr. Salloway and Dr. Edelmayer discuss what the treatment is, how it is administered, what it was designed to do, who is eligible to receive it and steps for accessing it. Viewers will also learn how to find more information and support through the Alzheimer’s Association. For more information, visit us at alz.org or call 1-800-272-3900.
- Advertisement -
We used two separate classification systems, motor-phenotype and simplified motor-nonmotor subtypes, to compare risks for major disease milestones in PD. At a mean of...